Vabysmo 6 MG/0.05 ML syringe 0.05ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMEC4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,448
Award facts
- Contract value 100% obligated
- $30,447.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $30,447.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VABYSMO 6 mg/0.05 ml syringes. The contract is firm fixed-price with no set-aside designation and carries an ultimate completion date of January 14, 2026. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, maintaining SAM registration since July 2001 and demonstrating consistent performance across multiple therapeutic categories and product lines. The company's IDC ceiling value of $499.99 million, awarded on November 13, 2025, with a completion date of December 31, 2036, enables the Defense Logistics Agency to issue firm fixed-price delivery orders for branded and generic prescription medications, biologics, vaccines, and medical consumables to support military healthcare operations globally. The present delivery order represents routine procurement activity under this broader vendor relationship, reflecting DMS Pharmaceutical Group's competitive capability and established performance record in unrestricted federal pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2DR26FMEC4?
SPE2DR26FMEC4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FMEC4 worth?
The government has obligated $30,448 on SPE2DR26FMEC4.
Is contract SPE2DR26FMEC4 an order under another contract?
Yes. SPE2DR26FMEC4 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEC4 competed?
The extent of competition for SPE2DR26FMEC4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award